Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | AMG 340 |
Synonyms | |
Therapy Description |
AMG 340 is a T-cell engager that binds to PSMA and CD3, which potentially induces antitumor activity (J Clin Oncol 42, 2024 (suppl 16; abstr e14587). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
AMG 340 | AMG-340|AMG340|TNB-585|TNB 585 | CD3 Antibody 99 PSMA Antibody 20 | AMG 340 is a T-cell engager that binds to PSMA and CD3, which potentially induces antitumor activity (J Clin Oncol 42, 2024 (suppl 16; abstr e14587). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT04740034 | Phase I | AMG 340 | A Study of AMG 340 in Subjects With Metastatic Castrate-Resistant Prostate Carcinoma | Completed | USA | 0 |